We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Update about the developing role of biosimilar medicines in the NHS in England and the safe, effective and consistent use of biosimilar medicines.
Details of the suspension of the marketing authorisation of Levothyroxine 100 microgram tablets, including MHRA investigations.
Instructions for integrating with the new production MORE platform API.
UK government interpretation of the requirements for labelling e-liquids for Northern Ireland.
The types of emissions a manufacturer or importer of e-cigarettes should notify us about.
For manufacturers reporting adverse incidents with IVC filters under the vigilance system.
Advice for manufacturers, members of the public and professional users of software or apps being used during the COVID-19 pandemic.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).